Global markets are on the rise this morning as hopes for the development of a virus vaccine intensify once again.
The first vaccine tested by Moderna and the U.S. National Institutes of Health uncovered an encouraging immune system boost, paving the way for an even larger study to see if the drug is powerful enough to protect against the virus.